tiprankstipranks
Intra-Cellular price target raised to $92 from $91 at BofA
PremiumThe FlyIntra-Cellular price target raised to $92 from $91 at BofA
14d ago
Intra-Cellular announces results for lumateperone as adjunctive therapy in MDD
PremiumThe Fly
Intra-Cellular announces results for lumateperone as adjunctive therapy in MDD
15d ago
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
PremiumPress Releases
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
15d ago
Intra-Cellular participates in a conference call with JPMorgan
PremiumThe FlyIntra-Cellular participates in a conference call with JPMorgan
1M ago
Intra-Cellular participates in a conference call with JPMorgan
PremiumThe Fly
Intra-Cellular participates in a conference call with JPMorgan
1M ago
Intra-Cellular sees FY24 CAPLYTA net produce sales $645M-$675M
PremiumThe Fly
Intra-Cellular sees FY24 CAPLYTA net produce sales $645M-$675M
2M ago
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
PremiumPress ReleasesIntra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
2M ago
Intra-Cellular price target raised to $107 from $100 at Canaccord
PremiumThe Fly
Intra-Cellular price target raised to $107 from $100 at Canaccord
2M ago
Intra-Cellular price target raised to $96 from $82 at Mizuho
PremiumThe Fly
Intra-Cellular price target raised to $96 from $82 at Mizuho
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100